This innovative 3-year project, based cooperatively at the University of Minnesota and Vanderbilt University, has convened a national Working Group of top legal and scientific experts to analyze current US federal and state law and regulation on translational genomics and to generate consensus guidance on what the law should be. The federal Precision Medicine Initiative (PMI) aims to use genomics and other analyses to accelerate development of more powerful and tailored treatments for cancer and other diseases. Yet federal and state genomics law is unclear and poorly understood, presenting a major obstacle to progress.
The project team will build a searchable online database of relevant law and an annotated bibliography for free public access, systematically collect and analyze a range of stakeholder inputs, convene a national public conference, and publish analyses and recommendations to help shape the law to support genomic medicine.
Project outcomes include:
- A resource-rich website that includes searchable databases of relevant federal and state laws and secondary sources;
- Consensus recommendations on what genomics law should be in four key domains (liability, quality, privacy & access, and framework);
- Publications by Working Group members offering further targeted analyses;
- Empirical analyses of perceived legal issues facing genomics;
- A national conference with archived videos available for free public access.
Read media coverage of LawSeq:
- "Pioneering study will establish the legal framework for genomic medicine," EurekAlert
- "LawSeq Effort Aims to Clarify Issues of Consent, Standards, and Liability in Genomic Medicine," Molika Ashford, GenomeWeb
- "VUMC part of national effort to improve genomic science laws, regulations," Bill Snyder, Research News at Vanderbilt
- "Genomic medicine law taking shape at the U," David Clarey, Minnesota Daily